Company

NKA Bio (Techstars '24)

Biotechnology Research 2401 W Belvedere Ave 7 employees

Employees: 7

www.nkabio.com LinkedIn Crunchbase

NKA Bio (Techstars '24) Overview

Headquarters: 2401 W Belvedere Ave
Website: www.nkabio.com
Industry: Biotechnology Research
Employees: 7
Founded: 2023
Funding: 30.0K
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

Antibody Engineering In Silico Drug Design Trauma Care Emergency Medicine Trauma Surgery Acute Care Surgery Military Medicine Combat Casualty Care TCCC Phage Display Assay Development Critical Care

About NKA Bio (Techstars '24)

NKA Bio is developing new medicines to improve critical care. Our lead product is NKA01, a temperature-stable antibody for trauma patients. When you are severely injured, it is a race against time to get to surgery. The average person dies 8 minutes before lifesaving treatment can be delivered. But in the future, when minutes count, our antibody will buy hours. At NKA Bio, our treatment presses pause on death. With an injection of NKA01 by EMS, our drug could buy more time for transport and lifesaving surgery.

NKA Bio (Techstars '24) Contact Details

People in AeroLeads: 3

NKA Bio (Techstars '24) Org Chart

Sample employees and titles

Name	Title	Location	Contact
Andrew Sanchez	Transitioning Navy Veteran - Full-time	Baltimore, Maryland, United States	View
Lana Kim	Student at Georgetown University		View
Susan Gann Hibbs	CEO and Co-founder Nka Bio (Techstars	Baltimore, Maryland, United States	View